本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kalvista Pharmaceuticals Inc

15.56
+0.17001.10%
盘后15.26-0.3000-1.93%19:39 EDT
成交量:71.06万
成交额:1,104.97万
市值:7.74亿
市盈率:-4.21
高:15.74
开:15.42
低:15.20
收:15.39
数据加载中...
2020/09/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/02

重要事件披露

8-K - Current report
2020/07/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/06/11

重要事件披露

8-K - Current report
2020/04/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/23

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/10

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/03/10

重要事件披露

Current report, items 2.02 and 9.01
2020/03/10

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/04

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/03

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/12/03

重要事件披露

Current report, items 2.02 and 9.01
2019/10/03

重要事件披露

Current report, item 5.07
2019/09/09

重要事件披露

Current report, items 2.02 and 9.01
2019/09/09

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/07/30

持股变动声明

Statement of changes in beneficial ownership of securities